DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Huprine X
Huprine X
Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: a Crystallographic, Kinetic and Calorimetric Study
X-Ray Structures of Torpedo Californica Acetylcholinesterase Complexed
1. Magnetic Nanoparticles: from Diagnosis to Therapy
Druglike Leads for Steric Discrimination Between Substrate
Structural Dynamics of Acetylcholinesterase and Its Implications in Reactivators Design Gianluca Santoni
Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders
Natural Product for the Treatment of Alzheimer's Disease
Click Chemistry in Situ
Research Strategies Developed for the Treatment of Alzheimer's
Estudio Farmacológico De Nuevos Anticolinesterásicos Híbridos Tacrina-Huperzina a Potencialmente Útiles Para El Tratamiento De La Enfermedad De Alzheimer
Pharmacodynamics of Cholinesterase Inhibitors Suggests Add-On
Acetylcholinesterase Inhibitors of Natural Origin
Development of 2-Methoxyhuprine As Novel Lead for Alzheimer's Disease
Naphthyridine–6-Chlorotacrine Hybrids As a New Family of Anti-Alzheimer Agents Targeting Β-Amyloid, Tau, and Cholinesterase Pathologies
Neuroprotective Effects of the Multitarget Agent AVCRI104P3 in Brain of Middle-Aged Mice
Neuroprotective Natural Products Neuroprotective Natural Products
Clock/Sleep-Dependent Learning and Memory in Male 3Xtg-AD Mice At
Herbal Drugs: Ethnomedicine to Modern Medicine K.G
Top View
New Insights in Alzheimer's Disease
Protective Role of a Donepezil-Huprine Hybrid Against the -Amyloid (1-42) Effect on Human Erythrocytes
Probing the Structure of Acetylcholinesterase Inhibitors in Their Binding Site Using Solid State Nuclear Magnetic Resonance
Tylcholinesterase Inhibitors in the Treatment of Alzheimer's Disease
NIH Public Access Author Manuscript J Med Chem
Protective Effects of Pinus Halepensis Bark Extract and Nicotine
Theoretical and Experimental Approaches Aimed at Drug Design Targeting Neurodegenerative Diseases
(12) United States Patent (10) Patent No.: US 9,459,187 B2 Craft Et Al
New Tacrine-Huperzine a Hybrids (Huprines): Highly Potent Tight-Binding Acetylcholinesterase Inhibitors of Interest for the Treatment of Alzheimer’S Disease
Highlights on Synthetic, Natural, and Hybrid Cholinesterase
Binding Acetylcholinesterase (Ache) Inhibitors to Be Used in the Treatment of Alzheimer’S Disease (AD)
Multitarget Strategies in Search of Novel Drug Candidates Against Alzheimer’S Disease
Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis
Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis
(12) Patent Application Publication (10) Pub. No.: US 2013/0209985 A1 Hoke Et Al
WO 2U11/151359 a L
WO 2013/116702 Al 8 August 2013 (08.08.2013) P O P C T
Inhibitors of Acetylcholinesterase and Butyrylcholinesterase Meet Immunity